Cidel Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Buy
5,038
+348
+7% +$129K 0.09% 117
2026
Q1
$1.37M Buy
4,690
+1,024
+28% +$337K 0.07% 126
2025
Q4
$1.29M Buy
3,666
+272
+8% +$91.9K 0.09% 116
2025
Q3
$1.1M Buy
3,394
+523
+18% +$163K 0.06% 122
2025
Q2
$1.12M Buy
2,871
+286
+11% +$115K 0.07% 116
2025
Q1
$1.12M Buy
2,585
+288
+13% +$116K 0.07% 108
2024
Q4
$847K Buy
2,297
+237
+12% +$99.2K 0.06% 129
2024
Q3
$1.07M Hold
2,060
0.08% 112
2024
Q2
$1.12M Buy
2,060
+35
+2% +$18.5K 0.09% 101
2024
Q1
$1.05M Buy
2,025
+47
+2% +$23.4K 0.08% 112
2023
Q4
$933K Buy
+1,978
New +$915K 0.04% 122

Other funds holding ELV

Cidel Asset Management's ELV Position: Q2 2026 in Review

Cidel Asset Management increased its Elevance Health (ELV) stake by 7.4% in Q2 2026, buying an estimated $129K and bringing the position to 5,038 shares worth $1.95M. The position accounts for 0.09% of the portfolio, ranked #117.

Cidel Asset Management first reported a position in ELV in Q4 2023 and has held it in 11 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Cidel Asset Management held 5,038 shares of Elevance Health worth $1.95M as of Q2 2026.
  • Cidel Asset Management bought 348 Elevance Health shares in Q2 2026, an estimated $129K.
  • Elevance Health made up 0.09% of Cidel Asset Management's portfolio in Q2 2026, its #117 holding.
  • Cidel Asset Management first reported a position in Elevance Health in Q4 2023 and has held it in 11 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.